Potential biomarkers for the prognosis and treatment of HCC immunotherapy.

No abstract is available for this paper.

• Publication year

  2023

• Venue

  European Review for Medical and Pharmacological Sciences

• Publication date

  2023-03-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.26355/eurrev_202303_31569PMID 36930502
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Identification and Validation of Key Genes in Hepatocellular Carcinoma by Bioinformatics Analysis

  2021cited by this paper
• Tracheal chondrosarcoma: A case report, systematic review, and pooled analysis

  2021cited by this paper
• Identification and Exploration of Novel Macrophage M2-Related Biomarkers and Potential Therapeutic Agents in Endometriosis

  2021cited by this paper
• Arming Immune Cells for Battle: A Brief Journey through the Advancements of T and NK Cell Immunotherapy

  2021cited by this paper
• lncLocator 2.0: a cell-line-specific subcellular localization predictor for long non-coding RNAs with interpretable deep learning

  2021cited by this paper
• CD6 is a target for cancer immunotherapy

  2021cited by this paper
• Integrative Analysis of the Expression of SIGLEC Family Members in Lung Adenocarcinoma via Data Mining

  2021cited by this paper
• Siglec15 shapes a non-inflamed tumor microenvironment and predicts the molecular subtype in bladder cancer

  2021cited by this paper
• Patterns of transcription factor programs and immune pathway activation define four major subtypes of SCLC with distinct therapeutic vulnerabilities.

  2021cited by this paper
• Tumor-associated myeloid cells: diversity and therapeutic targeting

  2021cited by this paper
• clusterProfiler 4.0: A universal enrichment tool for interpreting omics data

  2021cited by this paper
• Targeting Metabolism to Improve the Tumor Microenvironment for Cancer Immunotherapy.

  2020cited by this paper
• Identification of immunological subtypes of hepatocellular carcinoma with expression profiling of immune-modulating genes

  2020cited by this paper
• Microenvironment characterization and multi-omics signatures related to prognosis and immunotherapy response of hepatocellular carcinoma

  2020cited by this paper
• Challenges of combination therapy with immune checkpoint inhibitors for hepatocellular carcinoma.

  2020cited by this paper
• Hepatocellular Carcinoma Mechanisms Associated with Chronic HCV Infection and the Impact of Direct-Acting Antiviral Treatment

  2020cited by this paper
• Prognostic values of immune scores and immune microenvironment-related genes for hepatocellular carcinoma

  2020cited by this paper
• SPEAQeasy: a scalable pipeline for expression analysis and quantification for R/bioconductor-powered RNA-seq analyses

  2020cited by this paper
• A two-arm, randomized, controlled, multi-centric, open-label phase-2 study to evaluate the efficacy and safety of Itolizumab in moderate to severe ARDS patients due to COVID-19

  2020cited by this paper
• Immunobiology and immunotherapy of HCC: spotlight on innate and innate-like immune cells

  2020cited by this paper
• Molecular subtypes based on immune-related genes predict the prognosis for hepatocellular carcinoma patients.

  2020cited by this paper
• A Thermostable mRNA Vaccine against COVID-19

  2020cited by this paper
• An mRNA Vaccine against SARS-CoV-2 — Preliminary Report

  2020cited by this paper
• Increased both PD–L1 and PD–L2 expressions on monocytes of patients with hepatocellular carcinoma was associated with a poor prognosis

  2020cited by this paper
• The evolving landscape of biomarkers for checkpoint inhibitor immunotherapy

  2019cited by this paper
• From NASH to HCC: current concepts and future challenges

  2019cited by this paper
• Dendritic cells in cancer immunology and immunotherapy

  2019cited by this paper
• Significance of tumor-infiltrating immunocytes for predicting prognosis of hepatitis B virus-related hepatocellular carcinoma

  2019cited by this paper
• The tumor organismal environment: role in tumor development and cancer immunotherapy.

  2019cited by this paper
• Therapeutic target database 2020: enriched resource for facilitating research and early development of targeted therapeutics

  2019cited by this paper
• B cell and B cell-related pathways for novel cancer treatments.

  2019cited by this paper
• ARHGAP9 suppresses the migration and invasion of hepatocellular carcinoma cells through up-regulating FOXJ2/E-cadherin

  2018cited by this paper
• Epigenetic Mechanisms and Events in Gastric Cancer-Emerging Novel Biomarkers

  2018cited by this paper
• Landscape of immune microenvironment in hepatocellular carcinoma and its additional impact on histological and molecular classification

  2018cited by this paper
• Tumor-infiltrating B cells: their role and application in anti-tumor immunity in lung cancer

  2018cited by this paper
• The Immune Landscape of Cancer.

  2018cited by this paper
• Understanding the tumor immune microenvironment (TIME) for effective therapy

  2018cited by this paper
• CAR-T cells targeting CLL-1 as an approach to treat acute myeloid leukemia

  2018cited by this paper
• Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries

  2018cited by this paper
• Immune Gene Expression Profile in Hepatocellular Carcinoma and Surrounding Tissue Predicts Time to Tumor Recurrence

  2018cited by this paper
• DGIdb 3.0: a redesign and expansion of the drug–gene interaction database

  2017cited by this paper
• DrugBank 5.0: a major update to the DrugBank database for 2018

  2017cited by this paper
• Tumor and Microenvironment Evolution during Immunotherapy with Nivolumab.

  2017cited by this paper
• HCV eradication induced by direct-acting antiviral agents reduces the risk of hepatocellular carcinoma.

  2017cited by this paper
• Immunology in the liver — from homeostasis to disease

  2016cited by this paper
• Pan-cancer immunogenomic analyses reveal genotype-immunophenotype relationships and predictors of response to checkpoint blockade

  2016cited by this paper
• CLEC12A-Mediated Antigen Uptake and Cross-Presentation by Human Dendritic Cell Subsets Efficiently Boost Tumor-Reactive T Cell Responses

  2016cited by this paper
• Spatial reconstruction of single-cell gene expression

  2015cited by this paper
• TCGAbiolinks: an R/Bioconductor package for integrative analysis of TCGA data

  2015cited by this paper
• The multilayered complexity of ceRNA crosstalk and competition

  2014cited by this paper
• Therapeutic cancer vaccines: past, present, and future.

  2013cited by this paper
• Inferring tumour purity and stromal and immune cell admixture from expression data

  2013cited by this paper
• GSVA: gene set variation analysis for microarray and RNA-Seq data

  2013cited by this paper
• Microenvironmental regulation of tumor progression and metastasis

  2013cited by this paper
• Bin2 Is a Membrane Sculpting N-BAR Protein That Influences Leucocyte Podosomes, Motility and Phagocytosis

  2012cited by this paper
• Alcoholic liver disease: pathogenesis and new therapeutic targets.

  2011cited by this paper
• A ceRNA hypothesis: the Rosetta Stone of a hidden RNA language?

  2011cited by this paper
• Inflammatory tumour microenvironment is associated with superior survival in hepatocellular carcinoma patients.

  2010cited by this paper
• The immunosuppressive tumor microenvironment in hepatocellular carcinoma

  2009cited by this paper
• edgeR: a Bioconductor package for differential expression analysis of digital gene expression data

  2009cited by this paper
• Gender Disparity in Liver Cancer Due to Sex Differences in MyD88-Dependent IL-6 Production

  2007cited by this paper
• Hepatitis B virus-related hepatocellular carcinoma: paradigms for viral-related human carcinogenesis

  2006cited by this paper
• Preparation and analysis of cSNP chip on hepatocellular carcinoma-related genes.

  2005cited by this paper
• Pathophysiology of hepatitis C virus infection and related liver disease.

  2004cited by this paper
• Hepatitis B virus infection.

  1998cited by this paper

• Cancer Vaccines: Molecular Mechanisms, Clinical Progress, and Combination Immunotherapies with a Focus on Hepatocellular Carcinoma

  2025cites this paper
• Correlation Between Low Cytoplasmic Expression of XBP1 and the Likelihood of Surviving Hepatocellular Carcinoma

  2024cites this paper
• Potential Immunotherapy Targets for Liver-Directed Therapies, and the Current Scope of Immunotherapeutics for Liver-Related Malignancies

  2023cites this paper
• A Comprehensive Review on Cancer Vaccines and Vaccine Strategies in Hepatocellular Carcinoma

  2023cites this paper
• Recent advances in treatment strategies for hepatocellular carcinoma with portal vein cancer thrombus.

  2023cites this paper